Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Doft, Bernard H. M.D.
WARNING LETTER
•Doft, Bernard H. M.D.•September 28, 2012

Doft, Bernard H. M.D. – FDA Warning Letter, Sep 28, 2012

Record Details

This FDA Warning Letter, Ref: 13-HFD-45-05-01, dated June 12, 2013, was issued to Bernard H. Doft, M.D., following an inspection from September 17-28, 2012. The inspection reviewed Dr. Doft's conduct of clinical investigation Protocol FVF4579, "A Phase III, Double-Masked, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of 0.5 mg and 2.0 mg Ranibizumab Administered Monthly or on an As-Needed Basis (PRN) in Patients with Subfoveal Neovascular Age-Related Macular Degeneration," for the investigational drug ranibizumab (Lucentis®) performed for Genentech, Inc.

The FDA identified three main violations of statutory requirements and FDA regulations:

1. **Failure to conduct the investigation according to the investigational plan [21 CFR 312.60]:** * Two subjects (704201, 704220) were enrolled despite not meeting the required BCVA inclusion criteria (20/40-20/320 Snellen equivalent). * BCVA was measured by uncertified personnel for 5 subjects (704201-7

Company
Doft, Bernard H. M.D.
Inspection date
September 28, 2012
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Thomas N. Moreno
  • Kassa Ayalew
View Company Profile

ID · d09ec772-f505-45b0-b26e-a850cbc40f34

Violation Codes3
21 CFR 312.6021 CFR 312.62(b)21 CFR 50.20

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Doft, Bernard H. M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.